Iovance Biotherapeutics, Inc. - Common Stock — Flux de trésorerie (NASDAQ:IOVA)

Afficher le graphique complet Full chart

Financials

Flux de trésorerie liés aux activités d'exploitation -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-302.41 M -270.79 M Flux de trésorerie liés aux activités d'investissement -317.85 M132 K256.45 M-155.24 M-96.41 M47.5 M 43.02 M Flux de trésorerie liés aux activités de financement 576.42 M239.27 M190.15 M462.96 M390.66 M300.77 M 251.79 M Flux de trésorerie disponible -205.13 M-227.94 M-292.76 M-361.82 M-352.98 M-336.24 M -305.02 M

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics, Inc. - Common Stock

Nouvelles

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

La vente à découvert d’Intellia progresse le plus parmi les biotechs

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Undercovered Stocks: Western Digital, SAP, Toast And More

Pacira (PCRX) Q1 Earnings Miss Estimates

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Regeneron (REGN) Surpasses Q1 Earnings and Revenue Estimates